Influence of clonidine on psychopathological, endocrine and respiratory effects of cholecystokinin tetrapeptide in patients with panic disorder

Psychopharmacology

Volumn 133, Issue 1, 1997, Pages 55-61

  Kellner, M ^a   Yassouridis, A ^a   Jahn, H ^a   Wiedemann, K ^a  

^a MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

Author keywords

CCK 4; Clonidine; Panic disorder; Pituitary hormones

Indexed keywords

CLONIDINE; CORTICOTROPIN; HYDROCORTISONE; PLACEBO; TETRAGASTRIN;

ADULT; ARTICLE; BLOOD GAS PARAMETERS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFECT; DRUG INDUCED DISEASE; FEMALE; HEART RATE; HUMAN; MALE; MENTAL DISEASE; ORAL DRUG ADMINISTRATION; PANIC; PRIORITY JOURNAL; RESPIRATORY FUNCTION; SYMPTOM;

ADRENERGIC ALPHA-AGONISTS; ADRENOCORTICOTROPIC HORMONE; ADULT; CLONIDINE; DOUBLE-BLIND METHOD; FEMALE; GROWTH HORMONE; HUMANS; HYDROCORTISONE; MALE; MIDDLE AGED; PANIC DISORDER; PROLACTIN; RESPIRATION; TETRAGASTRIN;

EID: 0030767127     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050371     Document Type: Article

References (35)

1. Abelson JL, Nesse RM, Vinik AI (1994) Pentagastrin infusions in patients with panic disorder. II. Neuroendocrinology. Biol Psychiatry 36:84-96
2. Baranowska B (1987) The effect of clonidine on pituitary hormone secretion in physiological and pathological states. J Cardiovasc Pharmacol 10 [suppl 12]: S235-S239
3. Biró E, Sarnyai Z, Penke B, Szabó G, Telegdy G (1993) Role of endogenous corticotropin-releasing factor in mediation of neuroendocrine and behavioral responses to cholecystokinin octapeptide sulfate ester in rats. Neuroendocrinology 57: 340-345
4. Bradwejn J (1993) Neurobiological investigations into the role of cholecystokinin in panic disorder. J Psychiatry Neurosci 18: 178-188
5. Bradwejn J, Koszyncki D (1994) Imipramine antagonism of the panicogenic effects of cholecystokinin tetrapeptide in panic disorder patients. Am J Psychiatry 151:261-263
6. Bradwejn J, Koszycki D, Couetoux du Terre A, Paradis M, Bourin M (1994a) Effects of flumazenil on cholecystokinin-tetrupeptide-induced panic symptoms in healthy volunteers. Psychopharmacology 114:257-261
7. Bradwejn J, Koszyncki D, Couetoux du Terre A, van Megen H, den Boer J, Westenberg H, Annable L (1994b) The panicogenic effects of cholecystokinin-tetrapeptide are antagonized by L-365,260, a central cholecystokinin receptor antagonist, in patients with panic disorder. Arch Gen Psychiatry 51:486-493
8. Charney DS, Heninger GR (1986) Abnormal regulation of noradrenergic function in panic disorders. Arch Gen Psychiatry 43:1042-1054
9. Charney DS, Heninger GR, Redmond DE (1983) Yohimbine induced anxiety and increased noradrenergic function in humans: effects of diazepam and clonidine. Life Sci 33:19-29
10. Coplan JD, Liebowitz MR, German JM, Fyer AJ, Dillon DJ, Campeas RB, Davies SO, Martinez J, Klein DF (1992) Noradrenergic function in panic disorder effects of intravenous clonidine pretreatment on lactate induced panic. Biol Psychiatry 31:135-146
11. Crawley JN, Ninan PT, Pickar D, Chrousos GP, Linnoila M, Skolnick P, Paul SM (1985) Neuropharmacological antagonism of the β-carboline-induced "anxiety" response in rhesus monkeys. J Neurosci 5:477-485
12. Dillon DJ, Gorman JM, Liebowitz MR et al. (1987) The measurement of laclate-induced panic and anxiety. Psychiatry Res 20:97-105
13. Giguère V, Labrie F (1983) Additive effects of epinephrine and corticotropin-releasing factor (CRF) on adrenocorticotropin release in rat anterior pituitary cells. Biochem Biophys Res Commun 110:456-462
14. Haas DA, Sturtridge WC, George SR (1990) Differential alpha-1 and alpha-2 adrenergic effects on hypothalamic corticotropin-releasing factor and plasma adrenocorticotropin. Neuroscience 38:693-701
15. Holsboer F, von Bardeleben U, Buller R, Heuser I, Steiger A (1987) Stimulation response of corticotropin-releasing hormone (CRH) in patients with depression, alcoholism and panic disorder. Horm Metab Res 19:80-88
16. Koss MC, Christensen HD (1979) Evidence for a central postsynaptic action of clonidine. Naunyn-Schmiedeberg's Arch Pharmacol 307:45-50
17. Koszycki D, Zacharko RM, Le Mélledo JM, Bradwejn J (1996) The effecls of CCK-4 in normal individuals: comparison of panickers and nonpanickers. Eur Psychopharmacol 6 [suppl 3]: 206
18. Lanes R, Herrera A, Palacios A, Moncada G (1983) Decreased secretion of cortisol and ACTH after oral clonidine administration in normal adults. Metabolism 32:568-570
19. Le Mellédo JM, Bradwejn J, Koszycki D, Jerabek I, Jolicoeur F (1996) The role of the beta adrenergic system in CCK-4 induced panic symptoms. Eur Psychopharmacol 6 [suppl 3]: 114
20. Liebsch G, Landgraf R, Gerstberger R, Probst JC, Wotjak CT, Engelmann M, Holsboer F, Montkowski A (1995) Chronic infusion of a CRH-1 receptor antisense oligodeoxynucleotide into the central nucleus of the amygdala reduced anxiety-related behavior in socially defeated rats. Regul Pept 59:229-239
21. Milsom SR, Donald RA, Espiner EA, Nicholls MG, Livesey JH (1986) The effect of peripheral catecholamine concentrations on the pituitary-adrenal response to corlicotrophin releasing factor in man. Clin Endocrinol 25:241-246
22. de Montigny C (1989) Cholecystokinin tetrapeptide induces panic-like attacks in healthy volunteers. Arch Gen Psychiatry 46: 511-517
23. Nutt D, Lawson C (1992) Panic attacks a neurochemical overview of models and mechanisms. Br J Psychiatry 160:165-178
24. Skutella T, Criswell H, Moy C, Probst JC, Breese G, Jirikowsky GF, Holsboer F (1994) Antisense oligodeoxynucleotide complementary to corticotropin-releasing hormone mRNA reduces anxiety in shuttle-box performance. Neuroreport 5:2181-2185
25. Slowinska-Srzednicka J, Zgliczynski S, Soszynski P, Pucilowska J, Wierzbicki M, Jeske W (1988) Effect of clonidine on beta-endorphin, ACTH and cortisol secretion in essential hypertension and obesity. Eur J Pharmacol 35:115-121
26. Smythe GA, Edwards SR (1991) A role for central postsynaptic α2-adrenoceptors in glucoregulation. Brain Res 562: 225-229
27. Spitzer RL et al. (1987) Structured clinical interview for DSM-III-R (SCID). New York State Psychiatric Institute, N.Y.
28. Stein MB, Uhde TW (1988) Cortisol response to clonidine in panic disorder: comparison with depressed patients and normal controls. Biol Psychiatry 24:322-330
29. Uhde TW, Boulenger J-P, Post RM, Siever LJ, Vittone BJ, Jimerson DC, Roy-Byrne PP (1984) Fear and anxiety: relationship to noradrenergic function. Psychopathology 17 [suppl 3]: 8-23
30. Uhde TW, Vittone BJ, Siever LJ, Kaye WH, Post RM (1986) Blunted growth hormone response to clonidine in panic disorder patients. Biol Psychiatry 21:1077-1081
31. Vale W, Rivier C (1977) Substances modulating the secretion of ACTH by cultured anterior pituitary cells. Fed Proc 36: 2094-2099
32. Valentino RJ, Foote SL, Aston-Jones G (1986) Corticotropin releasing factor activates noradrenergic neurons of the locus ceruleus. Brain Res 270:363-367
33. van Megen HJGM, Westenberg HGM, den Boer JA, Haigh JRM, Traub M (1994) Pentagastrin induced panic attacks: enhanced sensitivity in panic disorder patients. Psychopharmacology 114: 449-455
34. Wiedemann K, Herzog L, Kellner M (1995) Atrial natriuretic hormone inhibits corticotropin-releasing hormone-induced prolactin release in man. J Psychiatry Res 29:51-580
35. Zacny E, Bugajski J (1984) Effect of intracerebroventricular clonidine on serum corticosterone in rats. Horm Res 20:116-123